Hancock Jaffe Hancock Jaffe
  • Home
  • About
    • Our History
    • Senior Management
    • Board Of Directors
    • Medical Advisory Board Members
  • Products
    • The VenoValve®
    • CoreoGraft® – Bypass Graft
  • Contact
  • Careers
  • Investors
    • Overview
    • Investor Presentation
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • Proxy Information
Hancock Jaffe Hancock Jaffe
  • Home
  • About
    • Our History
    • Senior Management
    • Board Of Directors
    • Medical Advisory Board Members
  • Products
    • The VenoValve™
    • CoreoGraft™ – Bypass Graft
  • Contact
  • Careers
  • Investors
    • Overview
    • Investor Presentation
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • Proxy Information

Press Releases

Investors
  • Overview
  • Investor Presentation
  • News / Events
    • Recent News / Events
    • Press Releases
    • Articles & Publications
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Profile
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
  • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Proxy Information
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • Recent News / Events
  • Press Releases
  • Articles & Publications
  • IR Calendar
  • Email Alerts

Hancock Jaffe Enrolls Four Additional Patients for First-in-Human VenoValve Study

Mar 21, 2019

Hancock Jaffe Announces Successful Start to CoreoGraft Study at Texas Heart Institute

Mar 18, 2019

Hancock Jaffe Completes $2.7 Million Private Placement of Common Stock

Mar 13, 2019

Hancock Jaffe Successfully Starts First-in-Human VenoValve Study

Feb 19, 2019

Hancock Jaffe Announces Objectives for Upcoming CoreoGraft Study

Jan 28, 2019

Dr. Marc H. Glickman to Present at 6th Israeli Vascular Access Conference

Jan 15, 2019

Hancock Jaffe Announces End Points for First-in-Human VenoValve Study

Jan 9, 2019

Hancock Jaffe Receives Approval for First-in-Human VenoValve Study

Dec 17, 2018

Hancock Jaffe Announces January CoreoGraft Study at the Texas Heart Institute

Dec 4, 2018

Hancock Jaffe Updates Status of Application to INVIMA for First-In-Human VenoValve Trial in Colombia

Nov 20, 2018
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    Copyright© 2021 by Hancock Jaffe Laboratories, Inc. All Rights Reserved | Terms of Use & Privacy Policy | Designed by Velocidi
    Show / Refresh / Reset / Delete
    Views until show: 5
    Seconds until show: 5
    By using this website, you consent to the use of cookies, as described in our privacy policy.Accept